5.00% p.a. Early Redemption Worst of GOAL

Underlying: AbbVie / Gilead / Johnson & Johnson SSPA/EUSIPA Product Type: Reverse Convertibles (1220) Valor: 55013633 / ISIN: CH0550136334

Last update 27.11.2020
  • Bid

    98.66 %
    Volume: 10'000

  • Ask

    99.66 %
    Volume: 10'000

CurrencyUSD
IssuerUBS AG, London Branch
Settlementphysical
Fixing date26.06.2020
Expiry26.06.2023
Sideways return13.15% / 4.88% p.a.
Unit price1'000.00 USD
Underlying price1)
AbbVie
Gilead
Johnson & Johnson

104.89 USD
60.03 USD
144.00 USD
Display
  • Product chart
1) Prices are 15 Min. delayed